» Articles » PMID: 10688854

Metabolism of Chemical Carcinogens

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2000 Feb 26
PMID 10688854
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

The transformation of chemicals is important in carcinogenesis, both in bioactivation and detoxification. Major advances in the past 20 years include appreciation of the migration of reactive electrophiles, the ability of Phase II conjugating enzymes to activate chemicals, understanding of the human enzymes, the realization that DNA modification can result from endogenous chemicals, and the demonstration that cancers can result from the metabolism of chemicals to non-covalently bound products. Pathways of transformation in which major insight was gained during the past 20 years include nitropolycyclic hydrocarbons, polycyclic hydrocarbons and their diols, vinyl halides and dihaloalkanes. Advances in analytical methods and recombinant DNA technology contributed greatly to the study of metabolism of chemical carcinogens. Major advances have been made in the assignment of roles of individual enzymes in reactions. The knowledge developed in this field has contributed to growth in the areas of chemoprevention, molecular epidemiology and species comparisons of risk. Some of the areas in which future development relevant to carcinogen metabolism is expected involve pathways of transformation of certain chemicals, regulation of genes coding for many of the enzymes under consideration and genomics.

Citing Articles

Gene clusters-based pathway enrichment analysis identifies four pan-cancer subtypes with distinct molecular and clinical features.

Xu M, Ai H, Wang D, Wang X Funct Integr Genomics. 2024; 24(6):224.

PMID: 39607532 DOI: 10.1007/s10142-024-01501-0.


Association Between Polymorphisms and Esophageal Cancer Susceptibility: A Case-control Study.

Kaya Z, Gursoy S In Vivo. 2023; 37(2):868-878.

PMID: 36881057 PMC: 10026655. DOI: 10.21873/invivo.13155.


The Use of Human Biomonitoring to Assess Occupational Exposure to PAHs in Europe: A Comprehensive Review.

Louro H, Gomes B, Saber A, Iamiceli A, Goen T, Jones K Toxics. 2022; 10(8).

PMID: 36006159 PMC: 9414426. DOI: 10.3390/toxics10080480.


Identification of CYP 2A6 inhibitors in an effort to mitigate the harmful effects of the phytochemical nicotine.

Goyal N, Sridhar J, Do C, Bratton M, Shaik S, Jiang Q J Cancer Metastasis Treat. 2021; 7.

PMID: 34722929 PMC: 8555909. DOI: 10.20517/2394-4722.2020.143.


Recent Updates on Marine Cancer-Preventive Compounds.

Dyshlovoy S Mar Drugs. 2021; 19(10).

PMID: 34677457 PMC: 8537284. DOI: 10.3390/md19100558.